Showing results (421-430 of 2,733) with videos related to
Sort By:
Pageof 274
Pharmacogenomics|August 2, 2014
Functional role of miRNA in cardiac resynchronization therapyCelestino Sardu, Raffaele Marfella, Gaetano Santulli, et al.Pharmacogenomics|April 11, 2013
New genetic associations in thiopurine-related bone marrow toxicity among inflammatory bowel disease patientsWilliam Zabala, Raquel Cruz, Manuel Barreiro-de Acosta, et al.Pharmacogenomics|April 11, 2013
Pharmacogenomics of bipolar disorderGiovanni Severino, Alessio Squassina, Marta Costa, et al.Pharmacogenomics|May 9, 2013
Impact of CYP2C9 polymorphisms on the vulnerability to pharmacokinetic drug-drug interactions during acenocoumarol treatmentLiliane Gschwind, Victoria Rollason, Françoise Boehlen, et al.Pharmacogenomics|May 9, 2013
Evaluation of 5-fluorouracil pharmacokinetic models and therapeutic drug monitoring in cancer patientsAndré Bp van Kuilenburg, Jan Gerard MaringPharmacogenomics|February 12, 2013
Company profile: Aviir, IncMichael Beggs, William H Biggs, Cynthia FrenchPharmacogenomics|February 12, 2013
Characterization of the CYP2D6 gene locus and metabolic activity in Indo- and Afro-Trinidadians: discovery of novel allelic variantsLazara Karelia Montané Jaime, Anthony Lalla, Werner Steimer, et al.Pharmacogenomics|February 12, 2013
Influence of genetic polymorphisms in the glutamatergic and GABAergic systems and their interactions with environmental stressors on antidepressant responseMengjia Pu, Zhijun Zhang, Zhi Xu, et al.Pharmacogenomics|February 12, 2013
NAT2 sequence polymorphisms and acetylation profiles in IndiansNaazneen Khan, Veena Pande, Aparup DasPharmacogenomics|February 27, 2013
Rare-variant genome-wide association studies: a new frontier in genetic analysis of complex traitsMichael J WagnerPageof 274